Table 2.
Clinical presentation | Previous list* | Master list | Accepted round 1 | Accepted round 2 | Accepted round 3 | Rejected |
Neurological | 7 | 17 | 7 | 11 | 14 | 0 |
Vaccine preventable diseases | 0 | 12 | 11 | 11 | 12 | 0 |
Electrolytes and laboratory abnormalities | 8 | 15 | 4 | 7 | 10 | 1† |
Cardiovascular | 6 | 12 | 1 | 6 | 9 | 0 |
Respiratory | 4 | 6 | 4 | 5 | 6 | 0 |
Renal | 3 | 5 | 1 | 3 | 5 | 0 |
Fracture or falls | 4 | 6 | 3 | 3 | 4 | 0 |
Haemorrhagic event | 3 | 5 | 1 | 2 | 3 | 0 |
Gastrointestinal | 4 | 4 | 0 | 3 | 3 | 0 |
Endocrine | 4 | 6 | 3 | 3 | 3 | 0 |
Genitourinary | 2 | 3 | 1 | 2 | 2 | 0 |
Sexually transmitted infections | 0 | 1 | 0 | 1 | 1 | 0 |
Other | 0 | 10 | 5 | 8 | 9 | 0 |
Total† | 45 | 102 | 41 | 65 | 81 | 1 |
*The list of PPMRHs previously developed for the general Australian population.13 14
†NOTE: Totals are not cumulative as during the rating process, panellists suggested that some indicators should be merged or split.
PPMRHs, potentially preventable medication-related hospitalisations.